Results
|
8481.
|
|
|
8482.
|
|
|
8483.
|
|
|
8484.
|
|
|
8485.
|
|
|
8486.
|
|
|
8487.
|
|
|
8488.
|
|
|
8489.
|
|
|
8490.
|
p53 suppresses c-Myb-induced trans-activation and transformation by recruiting the corepressor mSin3A. [electronic resource] by
- Tanikawa, Jun
- Nomura, Teruaki
- Macmillan, Elizabeth M
- Shinagawa, Toshie
- Jin, Wanzhu
- Kokura, Kenji
- Baba, Daichi
- Shirakawa, Masahiro
- Gonda, Thomas J
- Ishii, Shunsuke
Producer: 20050225
In:
The Journal of biological chemistry vol. 279
Availability: No items available.
|
|
8491.
|
|
|
8492.
|
|
|
8493.
|
Addition of S-1 to the epidermal growth factor receptor inhibitor gefitinib overcomes gefitinib resistance in non-small cell lung cancer cell lines with MET amplification. [electronic resource] by
- Okabe, Takafumi
- Okamoto, Isamu
- Tsukioka, Sayaka
- Uchida, Junji
- Hatashita, Erina
- Yamada, Yuki
- Yoshida, Takeshi
- Nishio, Kazuto
- Fukuoka, Masahiro
- Jänne, Pasi A
- Nakagawa, Kazuhiko
Producer: 20090716
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15
Availability: No items available.
|
|
8494.
|
|
|
8495.
|
Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury. [electronic resource] by
- Wagenaar, Gerry T M
- Laghmani, El Houari
- Fidder, Melissa
- Sengers, Rozemarijn M A
- de Visser, Yvonne P
- de Vries, Louwe
- Rink, Rick
- Roks, Anton J M
- Folkerts, Gert
- Walther, Frans J
Producer: 20131114
In:
American journal of physiology. Lung cellular and molecular physiology vol. 305
Availability: No items available.
|
|
8496.
|
Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors. [electronic resource] by
- Smith, V E
- Sharma, N
- Watkins, R J
- Read, M L
- Ryan, G A
- Kwan, P P
- Martin, A
- Watkinson, J C
- Boelaert, K
- Franklyn, J A
- McCabe, C J
Producer: 20130930
In:
The Journal of clinical endocrinology and metabolism vol. 98
Availability: No items available.
|
|
8497.
|
|
|
8498.
|
|
|
8499.
|
|
|
8500.
|
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial. [electronic resource] by
- Shaw, Alice T
- Felip, Enriqueta
- Bauer, Todd M
- Besse, Benjamin
- Navarro, Alejandro
- Postel-Vinay, Sophie
- Gainor, Justin F
- Johnson, Melissa
- Dietrich, Jorg
- James, Leonard P
- Clancy, Jill S
- Chen, Joseph
- Martini, Jean-François
- Abbattista, Antonello
- Solomon, Benjamin J
Producer: 20171215
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|